Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. - Wikidata - awgldk - TriplyDB

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

http://www.wikidata.org/entity/Q55067143

about

Antibiotics for Staphylococcus aureus pneumonia in adults Antibiotics for Staphylococcus aureus pneumonia in adults Evolution of resistance to a last-resort antibiotic in Staphylococcus aureus via bacterial competition Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci MC21-A, a bactericidal antibiotic produced by a new marine bacterium, Pseudoalteromonas phenolica sp. nov. O-BC30(T), against methicillin-resistant Staphylococcus aureus Vancomycin heteroresistance in bloodstream isolates of Staphylococcus capitis Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications Antimicrobial resistance: the example of Staphylococcus aureus Bacterial wall as target for attack: past, present, and future research Prevalence of antimicrobial resistance in bacteria isolated from central nervous system specimens as reported by U.S. hospital laboratories from 2000 to 2002 Mechanisms of vancomycin resistance in Staphylococcus aureus Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia Structure-based mechanism of lipoteichoic acid synthesis by Staphylococcus aureus LtaS Crystal structure of a phenol-coupling P450 monooxygenase involved in teicoplanin biosynthesis Structure and nucleotide specificity of Staphylococcus aureus dihydrodipicolinate reductase (DapB)Structural features and kinetic characterization of alanine racemase fromStaphylococcus aureus(Mu50)Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus Maggot Therapy: The Science and Implication for CAM Part I-History and Bacterial Resistance Tigecycline: first of a new class of antimicrobial agents Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis.In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces Vancomycin activates σ(B) in vancomycin-resistant Staphylococcus aureus resulting in the enhancement of cytotoxicity The nonantibiotic small molecule cyslabdan enhances the potency of β-lactams against MRSA by inhibiting pentaglycine interpeptide bridge synthesis Mechanism and inhibition of saFabI, the enoyl reductase from Staphylococcus aureus High Glucose Concentration Promotes Vancomycin-Enhanced Biofilm Formation of Vancomycin-Non-Susceptible Staphylococcus aureus in Diabetic Mice Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages Evolution and molecular characterization of methicillin-resistant Staphylococcus aureus epidemic and sporadic clones in Cordoba, Argentina.Comparative study of the susceptibilities of major epidemic clones of methicillin-resistant Staphylococcus aureus to oxacillin and to the new broad-spectrum cephalosporin ceftobiprole.Corneal Infection Therapy with Topical Bacteriophage Administration Coagulase-negative staphylococci.A mutation in the PP2C phosphatase gene in a Staphylococcus aureus USA300 clinical isolate with reduced susceptibility to vancomycin and daptomycin.A 5' nuclease PCR (TaqMan) high-throughput assay for detection of the mecA gene in staphylococci Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.

P2860

Q24234284-870E7424-BF6A-488F-9F84-2F226C92F4E6 Q24240226-9DEC41CC-E3F3-40F6-974B-0AE7F11DF98C Q24490083-34ECC626-9675-43AA-9A25-213CFFCB2BCF Q24519004-783F5E3E-92F0-40CE-9EF9-28861EC75943 Q24530652-B497D8A9-66E9-4CF1-A517-56E7D61B000B Q24550612-BAD6A863-F300-4AC3-8071-8A6D97503048 Q24554342-CEC02EE4-7C87-47F2-9122-7DC617E91AAC Q24646621-2BD12EC8-0E12-4F0A-BEA9-40622502BE05 Q24646677-4282C3F6-55BD-4123-BA0E-2BDDFB47038B Q24676363-BB32549F-C923-4330-B713-F20CB620CFAD Q24681486-0DB89833-BF5F-40C7-84B2-F0663C434705 Q24797274-81F1E3DD-9ABD-4D9A-B281-0B57A9274CA6 Q26829312-E413C83C-78B6-4F7E-B0B5-601AF9E89930 Q26853612-20E35B60-CB93-4853-8EEC-A6D33393CECD Q27001437-6B05AB2B-72F1-4C9A-808C-3DD0858DD3A1 Q27653515-CD540BE5-FF9C-48F3-93C2-E82F8925CAFD Q27667347-0D606AAC-1D20-4EF9-85A1-99B5E6DA6BBA Q27671283-D5C3EC87-70D7-4C78-93EE-0A2C4FC46BD7 Q27676379-0C0ECB2D-7AC0-4227-B442-8C0F7F1DC75B Q28078930-358DC827-2979-41C7-8A7F-AD7257497B45 Q28247168-1BD2C8AD-6A11-449E-A074-41353F3934DE Q28253736-67BBB2C4-0B5F-472E-BC2C-B8F3F030842C Q28362193-0DD7E147-A81D-49DC-AACD-F701C5787A1D Q28379547-B7358321-7AEC-4205-9803-1377D9E555C9 Q28385700-22C10781-E47C-4665-8AD8-952AE7B3E518 Q28476797-A21A41F8-4B0A-45E4-8F2C-938A879F6912 Q28484891-D439FA49-B22E-49FD-99D9-0985E42E3D57 Q28485592-17263095-ECB3-4E8B-8595-D864C37F873B Q28547029-A65A9488-6A39-4A09-A237-12D59D5CDAA9 Q28601378-3E78E66A-0AD2-45E7-9FA4-039BE1EF29BD Q29619365-BE723BE5-5D5A-4384-853A-E04B046E88F3 Q30341876-A2CAE7AA-2AF9-4DBE-8B70-B7CDFC825E73 Q30352398-4F717D02-C968-4588-A1CB-3FEC1646ED6A Q30369604-9AC907A6-CF1E-43BD-AFD9-FD1CE86EA86C Q30391422-F38A0260-D587-42AA-9FBB-E7682D71C76F Q30401758-74965EDC-ECFC-461A-B2A3-3E6D9809919B Q30455758-FD3F945D-84FE-4E08-B3FD-50D2EA3F87B1 Q30883581-228C0911-F19D-46AC-A2E0-6218DAF96A1B Q31109071-877D5A12-F388-40FD-A851-8757793B3D6A Q31704853-E869B924-69BB-4625-8D64-7866445FBE8F

P2860

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

http://www.wikidata.org/entity/Q55067143

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年学术文章

@wuu

1997年学术文章

@zh

1997年学术文章

@zh-cn

1997年学术文章

@zh-hans

1997年学术文章

@zh-my

1997年学术文章

@zh-sg

1997年學術文章

@yue

1997年學術文章

@zh-hant

name

Methicillin-resistant Staphylo ...... ced vancomycin susceptibility.

@en

Methicillin-resistant Staphylo ...... ced vancomycin susceptibility.

@nl

type

label

Methicillin-resistant Staphylo ...... ced vancomycin susceptibility.

@en

Methicillin-resistant Staphylo ...... ced vancomycin susceptibility.

@nl

prefLabel

Methicillin-resistant Staphylo ...... ced vancomycin susceptibility.

@en

Methicillin-resistant Staphylo ...... ced vancomycin susceptibility.

@nl

P1433

Q55067143-7C36330C-6EB5-497F-A3BC-F39BF99C971D

P1476

Q55067143-12B73F69-B415-4ACF-AC5B-366BAE09515D

P2093

Q55067143-2477BCC6-A3E9-4134-BBA8-53E631715E51

Q55067143-33C2A434-6785-498F-81CF-BA0C6C97FFF0

Q55067143-4A4A17E5-D99A-43F8-B983-88D6C1FAC9D9

Q55067143-C605F806-8AA6-4FBF-8840-66BC9C43DCD0

Q55067143-D1FD5CA8-3930-457F-A54D-ABF9901006DE

Q55067143-EE6ECA65-BE84-4185-8DDF-4DFC06A65625

P304

Q55067143-212A4D13-1E8E-47C1-A4A0-A46654B4FADC

P31

Q55067143-CC1EC601-9CAD-4C3A-A2B6-C8007CF7BBB8

P356

Q55067143-3A7904E2-2CD8-46CB-A53C-915D460DCFDF

P407

Q55067143-6981B84B-EF03-460E-BB21-50A4DE1DAAED

P433

Q55067143-772F7C9C-867B-4DCE-8265-F6A1079C238B

P478

Q55067143-C1A5F4DE-9B5A-40AC-916C-A1B8DAB39F87

P577

Q55067143-CA08DC45-D7A0-402D-84C9-FCD515736C93

P698

Q55067143-D625FB74-D154-44F0-A3F8-A5C8AAD9B7BB

P921

Q55067143-F8098127-EC33-44BD-A521-6714E239AA29

P356

P1433

Journal of Antimicrobial Chemotherapy

P1476

Methicillin-resistant Staphylo ...... ced vancomycin susceptibility.

@en

P2093

F C Tenover

http://www.w3.org/2001/XMLSchema#string

H Hanaki

http://www.w3.org/2001/XMLSchema#string

K Hiramatsu

http://www.w3.org/2001/XMLSchema#string

K Yabuta

http://www.w3.org/2001/XMLSchema#string

T Ino

http://www.w3.org/2001/XMLSchema#string

T Oguri

http://www.w3.org/2001/XMLSchema#string

P304

135-136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JAC/40.1.135

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

1997-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9249217

http://www.w3.org/2001/XMLSchema#string

P921

methicillin-resistant Staphylococcus aureus